Professor, Internal Medicine, University of Michigan Medical School
Internal Medicine
Dr. Kenneth A. Jamerson, MD
|
|
Give Review
Doctor Kenneth A. Jamerson, MD is an expert in the field of Internal Medicine. He graduated from University of Michigan Medical School. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Kenneth Jamerson is also a published physician. He has 32 paper published. The most recent paper is: Hypertension in African Americans Aged 60 to 79Years: Statement From the International Society of Hypertension in Blacks. Kenneth A. Jamerson accepts Medicare.
Publications
- Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks.
- Use of Renin-Angiotensin Inhibitors in People with Renal Artery Stenosis.
- Roll-in Experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) Study.
- The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension.
- Stenting and medical therapy for atherosclerotic renal-artery stenosis.
- Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
- Comparison of Benazepril Plus Amlodipine or Hydrochlorothiazide in High-Risk Patients With Hypertension and Coronary Artery Disease.
- Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
- A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
- Renal outcomes in hypertensive Black patients at high cardiovascular risk.
- Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH St...
- Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
- The attributable burden of hypertension: focus on CKD.
- 24-hour ambulatory blood pressure in the ACCOMPLISH trial.
- Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans.
- Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
- Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension.
- Periodontal disease and other nontraditional risk factors for CKD.
- Prompt, aggressive BP lowering in high-risk patients.
- The management of hypertension in the African American patient.
- Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of atherosclerotic renal artery stenosis.
- The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.
- A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
- Update on disparities in the pathophysiology and management of hypertension: focus on African Americans.
- Preventing chronic kidney disease in special populations.
- Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first rand...
- Surrogate markers for cardiovascular disease: functional markers.
- Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel bloc...
- The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue.
- Meeting the challenge to improve the treatment of hypertension in blacks.
- Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis.
Schools
University of Mi Med Sch
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1295811859 | |
| NPPES Provider LastName | JAMERSON | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 481059484 | |
| NPPES Provider State | MI | |
| Specialty Description | Cardiology | |
| Total Claim Count | 840.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295811859 |
| Last Name Of The Provider | JAMERSON |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
|
Dr. Darius K. Joshi, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Joyeeta G. Dastidar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charitha Gowda, MD |
|
|
Dr. Nancylee B. Stier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott F. Enderby, MD |
|
|
Dr. Yvonne T. Sesi, MD |
|
|
Dr. Ruo P. Zhu, MD |
|
Dr. Paul E. Lizotte, DO |
|
|
Vishal Abiraj, MB BS
This Doctor is OpenDoctor Recommended.
|